Glossary

Sample Size Calculation

The quantitative process of determining the minimum number of subjects required for a clinical study to detect a clinically meaningful effect with sufficient statistical power.

Get in touch Learn more

Wide-angle shot of a modern WeWork open floor plan with creative walls covered in AI system architecture diagrams, product team collaborating in standing desk area with industrial lighting.

STATISTICAL POWER ANALYSIS

What is Sample Size Calculation?

The quantitative methodology for determining the minimum number of subjects required in a clinical study to detect a clinically meaningful effect with sufficient statistical power while controlling for Type I and Type II errors.

Sample size calculation is the a priori statistical process of determining the minimum number of experimental units—patients, images, or readers—required to detect a pre-specified effect size with a defined statistical power (typically 80%) at a given alpha level (typically 0.05). The calculation mathematically balances the risk of a Type I error (false positive) against a Type II error (false negative), ensuring the study is neither underpowered to detect a true diagnostic improvement nor wastefully oversized, exposing excess subjects to experimental risk.

The computation requires four interconnected parameters: the significance criterion (α), the desired power (1-β), the minimum clinically important difference (effect size), and the expected variability (standard deviation) of the endpoint. In diagnostic imaging studies, sample size must additionally account for the prevalence of the target condition and the correlation structure inherent in multi-reader multi-case designs, where both reader and case variability inflate the required enrollment to maintain nominal statistical operating characteristics.

SAMPLE SIZE METHODOLOGY

Frequently Asked Questions

Precision in sample size calculation is the statistical bedrock of clinical validation. These answers address the most critical quantitative considerations for designing rigorous diagnostic AI studies.

Sample size calculation is the quantitative process of determining the minimum number of subjects required for a clinical study to detect a clinically meaningful effect with sufficient statistical power. It directly balances the risk of Type I error (false positive) and Type II error (false negative). For diagnostic AI, an underpowered study cannot reliably demonstrate that a model's sensitivity is non-inferior to a radiologist, rendering the regulatory submission invalid. Conversely, an overpowered study wastes resources and unnecessarily exposes patients to investigational protocols. The calculation ensures the trial is both ethically sound and scientifically definitive.

Enabling Efficiency, Speed & Accuracy

Intelligent Analysis, Decision & Execution

We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.

Talk to Us

Search across company data

Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.

Useful when people spend too long searching or get different answers from different systems.

Enterprise searchRAGPermissions

Automate internal workflows

Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.

Useful when repetitive work moves across multiple tools and teams.

AI agentsWorkflow automationGovernance

Add AI to products and internal tools

Build assistants, guided actions, or decision support into the software your team or customers already use.

Useful when AI needs to be part of the product, not a separate tool.

AI integrationDecision supportModel routing

SAMPLE SIZE CALCULATION

Key Statistical Inputs

The foundational parameters required to compute the minimum number of subjects needed to power a diagnostic accuracy study.

Significance Level (Alpha)

The probability of committing a Type I Error—concluding a diagnostic effect exists when it does not. Typically set at 0.05 (5%) for a two-sided test. This threshold defines the critical region for rejecting the null hypothesis. In diagnostic AI validation, alpha represents the acceptable risk of falsely claiming a model is superior to a radiologist when it is not. A lower alpha (e.g., 0.01) requires a larger sample size but provides stronger evidence.

0.05

Standard Alpha

Statistical Power (1 - Beta)

The probability of correctly rejecting a false null hypothesis—detecting a genuine diagnostic effect when it exists. Conventionally set at 80% or 90%. Power is the complement of Type II Error (Beta). A study with 80% power has a 20% chance of missing a true improvement in diagnostic accuracy. Higher power demands larger sample sizes but reduces the risk of an inconclusive trial.

80%

Minimum Target Power

Effect Size

The minimum clinically meaningful difference the study must detect. In diagnostic AI, this is often expressed as a delta in sensitivity or AUC improvement over a comparator. For example, a study might be powered to detect a 10% absolute improvement in sensitivity for detecting malignant nodules. Smaller effect sizes require exponentially larger samples. This parameter must be justified by clinical, not just statistical, significance.

0.05-0.10

Typical AUC Delta

Expected Prevalence

The anticipated proportion of subjects with the target condition in the study population. Prevalence directly impacts Positive Predictive Value (PPV) and Negative Predictive Value (NPV). In a low-prevalence setting (e.g., 5% disease rate), a study requires many more total subjects to accumulate sufficient positive cases for a stable sensitivity estimate. Enrichment strategies can reduce total sample size but may limit generalizability.

5-50%

Typical Range

Dropout and Attrition Rate

The anticipated proportion of enrolled subjects who will not complete the study protocol due to withdrawal, technical failure, or loss to follow-up. The calculated sample size must be inflated by a factor of 1 / (1 - dropout rate). For example, if 100 subjects are required and a 20% dropout is expected, 125 subjects must be enrolled. In imaging studies, attrition includes corrupted DICOM files and protocol violations.

10-20%

Common Inflation Factor

Allocation Ratio

The ratio of subjects assigned to each arm of a comparative study. A 1:1 ratio is most efficient for equal variance. Unequal ratios (e.g., 2:1) may be used to gather more safety data on a novel diagnostic or for ethical reasons. The allocation ratio directly impacts the sample size formula; imbalanced designs require a larger total sample size to maintain the same statistical power.

1:1

Optimal Allocation

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.

Limited slotsGet a Free AI Consultation

How We Work

Custom AI workflows for your Business

One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.